Literature DB >> 25753906

Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression?

Maja Kojovic1,2, Panagiotis Kassavetis1, Matteo Bologna3, Isabel Pareés1, Ignacio Rubio-Agusti4, Alfredo Berardelli3, Alfredo Beraredelli3, Mark J Edwards1, John C Rothwell1, Kailash P Bhatia1.   

Abstract

BACKGROUND: A number of neurophysiological abnormalities have been described in patients with Parkinson's disease, but very few longitudinal studies of how these change with disease progression have been reported. We describe measures of motor cortex inhibition and plasticity at 6 and 12 mo in 12 patients that we previously reported at initial diagnosis. Given the well-known interindividual variation in these measures, we were particularly concerned with the within-subject changes over time.
METHODS: Patients were assessed clinically, and transcranial magnetic stimulation (TMS) was used to measure motor cortical excitability, inhibition (short interval intracortical inhibition, cortical silent period), and plasticity (response to excitatory paired associative stimulation protocol) in both hemispheres. All measurements were performed 6 mo and 12 mo after the baseline experiments.
RESULTS: Asymmetry in clinical motor symptoms was reflected in asymmetry of plasticity and inhibition. In the group as a whole, little change was seen in any of the parameters over 12 mo. However, analysis of within-individual data showed clear correlations between changes in clinical asymmetry and asymmetry of response to paired associative stimulation protocol and cortical silent period.
CONCLUSIONS: Longitudinal changes in cortical silent period and response to paired associative stimulation protocol in Parkinson's disease reflect dynamic effects on motor cortex that are related to progression of motor signs. They are useful objective markers of early disease progression that could be used to detect effects of disease-modifying therapies. The decline in heightened plasticity that was present at disease onset may reflect failure of compensatory mechanisms that maintained function in the preclinical state.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  PAS; Parkinson's disease; progression; sensorimotor cortical plasticity; transcranial magnetic stimulation

Mesh:

Year:  2015        PMID: 25753906     DOI: 10.1002/mds.26167

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

Review 1.  Dysregulation of striatal projection neurons in Parkinson's disease.

Authors:  Goichi Beck; Arun Singh; Stella M Papa
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

2.  Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease.

Authors:  Arun Singh; Klaus Mewes; Robert E Gross; Mahlon R DeLong; José A Obeso; Stella M Papa
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-08       Impact factor: 11.205

Review 3.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

4.  Investigation of Motor Cortical Plasticity and Corticospinal Tract Diffusion Tensor Imaging in Patients with Parkinsons Disease and Essential Tremor.

Authors:  Ming-Kuei Lu; Chun-Ming Chen; Jeng-Ren Duann; Ulf Ziemann; Jui-Cheng Chen; Shang-Ming Chiou; Chon-Haw Tsai
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

5.  GABAergic changes in the thalamocortical circuit in Parkinson's disease.

Authors:  Annelies J M van Nuland; Hanneke E M den Ouden; Heidemarie Zach; Michiel F M Dirkx; Jack J A van Asten; Tom W J Scheenen; Ivan Toni; Roshan Cools; Rick C Helmich
Journal:  Hum Brain Mapp       Date:  2019-11-13       Impact factor: 5.038

6.  Perimenopausal women show modulation of excitatory and inhibitory neuromuscular mechanisms.

Authors:  Heidi Pesonen; Eija K Laakkonen; Pekka Hautasaari; Pauliina Aukee; Vuokko Kovanen; Sarianna Sipilä; Taija Finni; Ina M Tarkka
Journal:  BMC Womens Health       Date:  2021-03-31       Impact factor: 2.809

7.  Brain Connectomics' Modification to Clarify Motor and Nonmotor Features of Myotonic Dystrophy Type 1.

Authors:  Laura Serra; Matteo Mancini; Gabriella Silvestri; Antonio Petrucci; Marcella Masciullo; Barbara Spanò; Mario Torso; Chiara Mastropasqua; Manlio Giacanelli; Carlo Caltagirone; Mara Cercignani; Giovanni Meola; Marco Bozzali
Journal:  Neural Plast       Date:  2016-05-25       Impact factor: 3.599

Review 8.  Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases.

Authors:  Zhen Ni; Robert Chen
Journal:  Transl Neurodegener       Date:  2015-11-16       Impact factor: 8.014

9.  Usefulness of Transcranial Magnetic Stimulation to Assess Motor Function in Patients With Parkinsonism.

Authors:  Jaechan Park; Won Hyuk Chang; Jin Whan Cho; Jinyoung Youn; Yun Kwan Kim; Sun Woong Kim; Yun-Hee Kim
Journal:  Ann Rehabil Med       Date:  2016-02-26

10.  Nurr1 repression mediates cardinal features of Parkinson's disease in α-synuclein transgenic mice.

Authors:  Maria Argyrofthalmidou; Athanasios D Spathis; Matina Maniati; Amalia Poula; Maira A Katsianou; Evangelos Sotiriou; Maria Manousaki; Celine Perier; Ioanna Papapanagiotou; Zeta Papadopoulou-Daifoti; Pothitos M Pitychoutis; Pavlos Alexakos; Miquel Vila; Leonidas Stefanis; Demetrios K Vassilatis
Journal:  Hum Mol Genet       Date:  2021-07-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.